Home
About BioMark
Oncology Platform
- Biomark SSAT1 Assay
- BioMark Metabolic Panel
Investor Relations
Bio-Stream Diagnostics
- Bio-Stream Spectral Test
Recent Posts
Info & Contact

RECENT POSTS

Equities.com Interview with Rashid Ahmed CEO

By: superadmin | Tags: | Comments: 0 | January 23rd, 2015

You must be logged in to post a comment.

Click here to cancel reply.

Recent Posts

Richmond company looking for ‘holy grail’ in COVID-19 testing

Posted 2020-10-09

Dr. Horacio Bach – receives major grant from CIHR for COVID-19 antibody development

Posted 2020-03-31

BIOMARK’S LIQUID BIOPSY SCIENTIFIC PAPER TO BE FEATURED AS COVER ON CANCERS UPCOMING ISSUE

Posted 2019-08-19

National research team targets glioblastoma

Posted 2019-05-31

BIOMARK’S ABSTRACT FOR 2019 ASCO ONLINE PUBLICATION

Posted 2019-05-30

Sitemap

Home
About BioMark
Oncology Platform
- Biomark SSAT1 Assay
- BioMark Metabolic Panel
Investor Relations
Bio-Stream Diagnostics
- Bio-Stream Spectral Test
Recent Posts
Info & Contact

Latest Posts

Richmond company looking for ‘holy grail’ in COVID-19 testing
Dr. Horacio Bach – receives major grant from CIHR for COVID-19 antibody development
BIOMARK’S LIQUID BIOPSY SCIENTIFIC PAPER TO BE FEATURED AS COVER ON CANCERS UPCOMING ISSUE
National research team targets glioblastoma
BIOMARK’S ABSTRACT FOR 2019 ASCO ONLINE PUBLICATION

Site Policies

Terms and Conditions
Website and Privacy Policy

Contact Us

INVESTOR CORPORATE INQUIRES

RASHID A. BUX

CEO
604.370.0779
info@biomarkdiagnostics.com

Copyright © 2019 BioMark Diagnostics Inc. All rights reserved.

BioMark's mission is to provide universal access to a new paradigm in cancer diagnostics using metabolomics.